Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03960957
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
301
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
AbobotulinumtoxinA
OTHER:
Placebo
Sponsor
Galderma R&D